The UK-based company that’s striving to overcome the limitations of T cell receptor innovation

Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. When the FDA earlier this year approved the first T cell receptor (TCR) therapeutic to treat a solid tumor, the nod marked a turning point for the field of immunotherapies and personalized medicine. The approved product, Immunocore’s … Read more